| Cat. No. |
Product Name |
Effect
|
Purity |
Rare Diseases
|
| HY-139201A |
Poly-D-lysine hydrobromide (MW 70000-150000) |
Agonist |
99.86% |
Unkown |
| HY-139201 |
Poly-D-lysine hydrobromide (MW 30000-70000) |
Agonist |
/ |
Unkown |
| HY-W017018S4 |
L-Ornithine-d7 hydrochloride |
Activator |
99.90% |
Unkown |
| HY-112171 |
γ-L-Glutamyl-L-alanine |
Modulator |
98.0% |
Unkown |
| HY-12557 |
γ-Glutamylvaline |
Agonist |
99.94% |
Unkown |
| HY-W017018S2 |
L-Ornithine-1,2,3,4,5-13C5 hydrochloride |
Activator |
99.88% |
Unkown |
| HY-10171 |
NPS-2143 hydrochloride |
Antagonist |
99.98% |
Unkown |
| HY-103320A |
Calhex 231 hydrochloride |
Inhibitor |
99.81% |
Unkown |
| HY-N0546 |
Ligustroflavone |
Antagonist |
99.90% |
Unkown |
| HY-139201B |
Poly-D-lysine hydrobromide (MW 84000) |
Agonist |
/ |
Unkown |
| HY-W017018S |
L-Ornithine-d6 hydrochloride |
Activator |
99.92% |
Unkown |
| HY-11095 |
NPS 2390 |
Inhibitor |
99.90% |
Unkown |
| HY-122819 |
Calindol hydrochloride |
Agonist |
99.64% |
Unkown |
| HY-W017018S5 |
L-Ornithine-15N2 hydrochloride |
Activator |
98.90% |
Unkown |
| HY-121584 |
Lycoperodine-1 |
Agonist |
99.82% |
Unkown |
| HY-139201D |
Poly-D-lysine hydrobromide (MW 4000-15000) |
|
/ |
Unkown |
| HY-P4376A |
Gamma-Glu-Abu TFA |
Activator |
96.83% |
Unkown |
| HY-W843885 |
H-Glu-Thr-OH |
Activator |
98.63% |
Unkown |
| HY-103320B |
(1R,2R)-Calhex 231 hydrochloride |
Control |
98.45% |
Unkown |
| HY-117851 |
AC-265347 |
Agonist |
99.73% |
Unkown |
| HY-W017018S3 |
L-Ornithine-d2 hydrochloride |
Activator |
99.94% |
Unkown |
| HY-112171R |
γ-L-Glutamyl-L-alanine (Standard) |
Modulator |
99.29% |
Unkown |
| HY-50713 |
Calcium-Sensing receptor antagonist I |
Antagonist |
99.40% |
Unkown |
| HY-139201E |
Poly-D-lysine hydrobromide (MW 150000-300000) |
Agonist |
/ |
Unkown |
| HY-107773 |
GSK3004774 |
Agonist |
99.09% |
Unkown |
| HY-139201H |
Poly-D-lysine hydrobromide (MW ≥300000) |
Activator |
/ |
Unkown |
| HY-W017018B |
L-Ornithine monohydrochloride,suitable for cell culture |
Activator |
99.73% |
Unkown |
| HY-15104 |
Ronacaleret hydrochloride |
Antagonist |
99.81% |
Unkown |
| HY-70037AS |
Cinacalcet-d3 hydrochloride |
Agonist |
97.63% |
Unkown |
| HY-P11668 |
Gosicalcetide |
Agonist |
/ |
Unkown |
| HY-10167 |
Tecalcet |
Modulator |
/ |
Unkown |
| HY-153258 |
CaSR antagonist-1 |
Antagonist |
/ |
Unkown |
| HY-15106 |
SB-423557 |
Antagonist |
/ |
Unkown |
| HY-139201C |
Poly-D-lysine hydrobromide (MW 1000-5000) |
Activator |
/ |
Unkown |
| HY-P4376B |
Gamma-Glu-Abu acetate |
Activator |
99.87% |
Unkown |
| HY-P4376 |
Gamma-Glu-Abu |
Activator |
/ |
Unkown |
| HY-179475 |
KP-2067 |
Agonist |
/ |
Unkown |
| HY-14401B |
Encaleret sodium |
Antagonist |
/ |
Unkown |
| HY-70037S |
Cinacalcet-d3 |
Agonist |
/ |
Unkown |
| HY-109106B |
(Rac)-Upacicalcet |
|
95.0% |
Unkown |
| HY-103320 |
Calhex 231 |
Antagonist |
/ |
Unkown |
| HY-W777503 |
Calindol hydrochloride-13C,D2 |
|
/ |
Unkown |
| HY-P11832 |
CaSR agonist peptide-1 |
Agonist |
/ |
Unkown |
| HY-17613S |
Evocalcet-d4 |
Activator |
/ |
Unkown |
| HY-182543 |
NPS-467 |
Activator |
/ |
Unkown |
| HY-15105A |
SB-423562 hydrochloride |
Antagonist |
/ |
Unkown |
| HY-171446 |
TAK-075 |
Antagonist |
/ |
Unkown |
| HY-161113 |
Z8554052021 |
Activator |
/ |
Unkown |
| HY-W017018S1 |
L-Ornithine-1,2-13C2 hydrochloride |
Activator |
/ |
Unkown |
| HY-W653978 |
Cinacalcet-d4 hydrochloride |
Agonist |
/ |
Unkown |